Sponsor Pipeline

Jiangsu Genscend Biopharmaceutical Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07386743 A Phase III Study of GS101 Injection to Dupixent® Atopic Dermatitis (AD) Not Yet Recruiting
Phase 1
NCT07411755 A Phase 1 Clinical Study Comparing GS101 and Dupixent® After Subcutaneous Injection Atopic Dermatitis (AD) Recruiting
Disease Areas
Atopic Dermatitis (2)
Get alerts when Jiangsu Genscend Biopharmaceutical Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free